Lewis C. Pell

Founder at MetaCure (USA), Inc.

Lewis C. Pell

Lewis C. Pell

Founder at MetaCure (USA), Inc.

Overview
Career Highlights

Spine View, Inc.
Ancora Heart, Inc.
MetaCure (USA), Inc.

RelSci Relationships

2114

Number of Boards

18

Birthday

1945

Age

76

Contact Data
Trying to get in touch with Lewis C. Pell? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Lewis C. Pell likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Vice Chairman at Mount Sinai Health System, Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at International Flavors & Fragrances, Inc.

Relationship likelihood: Strong

Former Vice President, Campaign at Jewish Federation of Northern New Jersey, Inc.

Relationship likelihood: Strong

Partner, Private Transactions at Deerfield Management Company LP

Relationship likelihood: Strong

Trustee at The Mount Sinai Hospital

Relationship likelihood: Strong

Trustee at The Mount Sinai Hospital

Relationship likelihood: Strong

Founder at Arstasis, Inc.

Relationship likelihood: Strong

Vice Chairman at The Mount Sinai Hospital

Relationship likelihood: Strong

Vice Chairman & Board Member at St. Luke's-Roosevelt Hospital Center

Relationship likelihood: Strong

Managing Partner at Deerfield Management Company LP

Relationship likelihood: Strong

Paths to Lewis C. Pell
Potential Connections via
Relationship Science
You
Lewis C. Pell
Founder at MetaCure (USA), Inc.
Education
B.S. in Political Science

Brooklyn College is a senior college of the City University of New York, located in Brooklyn, New York, United States. Established in 1930 by the New York City Board of Higher Education, the College had its beginnings as the Downtown Brooklyn branches of Hunter College (then a women's college) and the City College of New York (then a men's college). With the merger of these branches, Brooklyn College became the first public coeducational liberal arts college in New York City. The 26-acre (110,000 m2) campus is known for its great beauty, and is often regarded as "the poor man's Harvard" because of its low tuition and reputation for academic excellence (former President, Robert Hess, responded to the moniker by saying "I like to think of Harvard as the rich man's Brooklyn College").

Career History
Co-Founder
2012 - Current

Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA.

Founder
2003 - Current

MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY.

Co-Founder
Tenure Unconfirmed

Sensome SAS develops remote monitoring invasive vascular medical devices. It focuses on turning invasive medical devices into connected healthcare devices. The company was founded by Franz Bozsak and Abdul Barakat and is headquartered in Massy, France.

Boards & Committees
Chairman
Prior

Spectrum Dynamics Medical Ltd. engages in the development, manufacture, and sale of single-photon emission computed tomography cardiac imaging equipment. Its products include VERITON, VERITON-CT, and D-SPECT Series. The company was founded by Yoel Zilberstien, Yaron Front, and Shlomo Ben Haim on February 6, 2013 and is headquartered in Caesarea, Israel.

Member, Board of Trustees
Current

Continuum Health Partners, Inc. was formed as a partnership of the Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center. The entity served as a parent corporation while the two hospital centers continued as separate business entities with their own constituent hospital campuses. Continuum hospitals delivered inpatient care through nearly 3,100 certified beds located in seven major facilities in Manhattan and Brooklyn, while providing outpatient care in private practice settings and ambulatory centers. Continuum treated patients in Brooklyn, Manhattan and Westchester County.

Member, Board of Trustees
Tenure Unconfirmed

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to our local and global communities. Encompassing the Icahn School of Medicine at Mount Sinai and seven hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is acclaimed internationally for its excellence in research, patient care, and education across a range of specialties. The Mount Sinai Health System was created from the combination of The Mount Sinai Medical Center and Continuum Health Partners, which both agreed unanimously to combine the two entities in July 2013.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100K - $500K
2017

National Jewish Health, Inc. provides healthcare services. It offers personalized medicines that prevents and treats respiratory, cardiac, immune and related disorders. The company was founded in 1899 and is headquartered in Denver, CO.

$100K - $500K
2016

National Jewish Health, Inc. provides healthcare services. It offers personalized medicines that prevents and treats respiratory, cardiac, immune and related disorders. The company was founded in 1899 and is headquartered in Denver, CO.

$50K - $100K
2010

National Jewish Health, Inc. provides healthcare services. It offers personalized medicines that prevents and treats respiratory, cardiac, immune and related disorders. The company was founded in 1899 and is headquartered in Denver, CO.

Political Donations
$5,000
2006

The Democratic Senatorial Campaign Committee is the only organization solely dedicated to electing a Democratic Senate. From grassroots organizing to candidate recruitment to providing campaign funds for tight races, the DSCC is working hard all year, every year to elect Democrats – and give President Obama the help he needs on Capitol Hill to move our country forward.

$10K
2005

Former Governor of New York

$1,000
2004

Former President of United States

Investments
Details Hidden

Visionsense Corp. develops novel visualization solutions. It offers stereoscopic vision system, an open architecture software-driven system that combines the functionality of the endoscope and the 3D capability of the operating room microscope to provide a visualization solution for the surgeon. The company was founded by Avi Yaron and Michael Goldstein in 1998 and is headquartered in New York, NY.

Details Hidden

Vision-Sciences, Inc. develops, manufactures, and markets innovative products for flexible endoscopy. The products and accessories are used within two industries: medical and industrial. Vision-Sciences, Inc. designs, manufactures, repairs, and markets flexible endoscopes for medical use and proprietary single-use sheaths (The EndoSheath® Technology) that slide over the insertion tube of the endoscope. The sheaths allow for quick, efficient endoscope turnover while ensuring a sterile procedure for each patient. Industrial endoscopes are designed, manufactured, repaired and marketed by the Machida Division located in Orangeburg, NY. These endoscopes (borescopes) are used primarily for aircraft maintenance, jet engine manufacturing and defense. Our History Vision-Sciences, Inc., was founded in 1990 to develop and market a proprietary line of flexible endoscopes designed to increase practice efficiency and reduce the risk of endoscopic cross-contamination. Dr. Fred E. Silverstein, a noted gastroenterologist, was convinced that the existing methods of reprocessing endoscopes - elaborate and difficult - could be improved upon. He invented a two-part system consisting of a reusable endoscope and a sterile, disposable sheath that would act as a barrier between the scope and the patient. The concept featured an endoscope containing only the optics, light bundles, and functional mechanisms. The key scope components referred to as the “channels” were not part of the reusable scope. Instead these difficult-to-clean components were incorporated into the disposable sheath unit. This sheath unit – better known as the EndoSheath® Technology – is the only part of the system that comes in contact with the patient. The reusable endoscope never comes in contact with the patient. Even biopsy and suction material is transferred through the disposable unit. This two-part system allows for quick turnaround time, less capital equipment and repair costs, and a dramatic reduction in the risk of cross-contamination. Since the company’s founding, Vision-Sciences, Inc. has received FDA Clearance to market EndoSheath® Technology in several endoscopy specialties: Laryngoscopy Cystoscopy Sigmoidoscopy Colonoscopy Gastroscopy Bronchoscopy Esophagoscopy Vision-Sciences, Inc. is actively pursuing ways to bring the EndoSheath® Technology to more areas of endoscopy. Vision-Sciences, Inc. currently has twenty-nine issued patents in the United States, as well as key patents issued in Europe, Japan, Canada, and a number of additional patent applications in process. The Company believes these patents provide very strong protection for its inventions. During April 2007, our Orangeburg facility underwent an expansion audit which was successfully completed and we were awarded International Organization for Standardization (ISO) 13485: 2003 certification for this location. This certification allowed us to start shipping scopes from our Orangeburg facility, in addition to shipments from our Natick facility. The Natick and Orangeburg facilities are registered with the FDA as medical device manufacturers. As a result, these facilities are subject to the FDA’s QSR, which regulate their design, manufacturing, testing, quality control and documentation procedures. We are also required to comply with the FDA’s labeling requirements, as well as its information reporting regulations. In August 2005, our Natick quality system certification was updated to establish conformance with ISO 13485: 2003 and continued conformance with Medical Devices Directive (MDD) 93/42/EEC and the Canadian Medical Device Regulations (CMDR). In addition to the three-year certification audits, we undergo annual surveillance audits to confirm that we are maintaining our quality system.

Details Hidden

CuraSeal, Inc. develops devices for minimally invasive treatment of intestinal fistulas. It provides interventional devices for treating gastrointestinal tract disorders. The company was founded by Akshay Mavani and Harold F. Carrison in 2007 and is headquartered in Santa Clara, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lewis C. Pell. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lewis C. Pell's profile does not indicate a business or promotional relationship of any kind between RelSci and Lewis C. Pell.